Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes
Abstract Using in vitro, in vivo and patient-based approaches, we investigated the potential of circulating microRNAs (miRNAs) as surrogate biomarkers of myocardial steatosis, a hallmark of diabetic cardiomyopathy. We analysed the cardiomyocyte-enriched miRNA signature in serum from patients with we...
Guardado en:
Autores principales: | D. de Gonzalo-Calvo, R. W. van der Meer, L. J. Rijzewijk, J. W. A. Smit, E. Revuelta-Lopez, L. Nasarre, J. C. Escola-Gil, H. J. Lamb, V. Llorente-Cortes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/78f141abab4d47499cb088d493932491 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pre-microRNA and mature microRNA in human mitochondria.
por: Eric Barrey, et al.
Publicado: (2011) -
Rapid generation of microRNA sponges for microRNA inhibition.
por: Joost Kluiver, et al.
Publicado: (2012) -
MicroRNA AND TUBERCULOSIS
por: V. V. Eremeev, et al.
Publicado: (2018) -
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
por: Yu Yamaura, et al.
Publicado: (2012) -
MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.
por: Ryan Cawood, et al.
Publicado: (2011)